Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | THRB | P10828 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | PLG | P00747 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 3/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.48 |
| ▸ | GABRD | O14764 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2059628 | 1.00 | LMNA (0.64) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL285020 | 1.00 | LMNA (0.64) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL728991 | 0.97 | NFKB1 (0.62) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL728986 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL28408226 | 0.86 | BLM (0.57) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL31390042 | 0.86 | LMNA (0.65) | LMNATHRBKMT2AMEN1ALDH1A1 | |
| SCHEMBL10962384 | 0.86 | OR51E2 (0.56) | LMNAKMT2AMEN1ALDH1A1ALOX15 | |
| SCHEMBL10961559 | 0.86 | OR51E2 (0.56) | LMNAKMT2AMEN1ALDH1A1ALOX15 | |
| SCHEMBL10957816 | 0.86 | OR51E2 (0.56) | LMNAKMT2AMEN1ALDH1A1ALOX15 | |
| SCHEMBL10964715 | 0.86 | OR51E2 (0.56) | LMNAKMT2AMEN1ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230000836-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION | 2023-01-05 | — | — | US | disclosed |
| US-11369590-B2 | PSMA binding ligand-linker conjugates and methods for using | PURDUE RESEARCH FOUNDATION (US) | 2022-06-28 | — | — | US | disclosed |
| EP-3656403-B1 | PREPARATION PROCESS OF PSMA BINDING LIGAND-LINKER CONJUGATES | PURDUE RESEARCH FOUNDATION (US) | 2022-05-11 | — | — | EP | disclosed |
| US-11318121-B2 | PSMA binding ligand-linker conjugates and methods for using | PURDUE RESEARCH FOUNDATION (US) | 2022-05-03 | — | — | US | disclosed |
| US-20210338641-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION | 2021-11-04 | — | — | US | disclosed |
| US-11155800-B2 | PSMA binding ligand-linker conjugates and methods for using | PURDUE RESEARCH FOUNDATION (US) | 2021-10-26 | — | — | US | disclosed |
| US-20210322388-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION | 2021-10-21 | — | — | US | disclosed |
| US-11083710-B2 | PSMA binding ligand-linker conjugates and methods for using | PURDUE RESEARCH FOUNDATION (US) | 2021-08-10 | — | — | US | disclosed |
| EP-3858347-A2 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | Purdue Research Foundation (US) | 2021-08-04 | — | — | EP | disclosed |
| EP-3838298-A2 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | Purdue Research Foundation (US) | 2021-06-23 | — | — | EP | disclosed |
| US-20140073763-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION (US) | 2014-03-13 | — | — | US | disclosed |
| US-20120322741-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION (US) | 2012-12-20 | — | — | US | disclosed |
| WO-2011106639-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION (US) | 2011-09-01 | — | — | WO | disclosed |
| US-20100324008-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION (US) | 2010-12-23 | — | — | US | disclosed |
| EP-2187965-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION (US) | 2010-05-26 | — | — | EP | disclosed |
| US-20100055735-A1 | EX VIVO FLOW CYTOMETRY METHOD AND DEVICE | LOW PHILIP STEWART | 2010-03-04 | — | — | US | disclosed |
| EP-2087337-A2 | EX VIVO FLOW CYTOMETRY METHOD AND DEVICE | Purdue Research Foundation (US) | 2009-08-12 | — | — | EP | disclosed |
| WO-2009026177-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION (US) | 2009-02-26 | — | — | WO | disclosed |
| WO-2008057437-A9 | EX VIVO FLOW CYTOMETRY METHOD AND DEVICE | LOW PHILIP S (US) | 2008-08-14 | — | — | WO | disclosed |
| WO-2008057437-A2 | EX VIVO FLOW CYTOMETRY METHOD AND DEVICE | PURDUE RESEARCH FOUNDATION (US) | 2008-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11083710-B2 | PSMA binding ligand-linker conjugates and methods for using | FOLH1, KLK3, PSMA1 | LMNA 2066/4885THRB 1567/4885KMT2A 2431/4885 |
| US-20210322388-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | FOLH1, KLK3, PSMA1 | LMNA 2066/4885THRB 1567/4885KMT2A 2431/4885 |
| US-11369590-B2 | PSMA binding ligand-linker conjugates and methods for using | FOLH1, KLK3, PSMA1 | LMNA 2066/4885THRB 1567/4885KMT2A 2431/4885 |
| US-11318121-B2 | PSMA binding ligand-linker conjugates and methods for using | FOLH1, KLK3, PSMA1 | LMNA 2066/4885THRB 1567/4885KMT2A 2431/4885 |
| US-11155800-B2 | PSMA binding ligand-linker conjugates and methods for using | FOLH1, KLK3, PSMA1 | LMNA 2077/4885THRB 1624/4885KMT2A 2362/4885 |
| US-20210338641-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | FOLH1, KLK3, PSMA1 | LMNA 2066/4885THRB 1567/4885KMT2A 2431/4885 |
| US-20120322741-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | FOLH1, KLK3, PSMA1 | LMNA 2077/4885THRB 1624/4885KMT2A 2362/4885 |
| US-20230000836-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | FOLH1, KLK3, PSMA1 | LMNA 2066/4885THRB 1567/4885KMT2A 2431/4885 |
| US-20100324008-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | FOLH1, KLK3, PSMA1 | LMNA 2066/4885THRB 1567/4885KMT2A 2431/4885 |
| US-20140073763-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | FOLH1, KLK3, PSMA1 | LMNA 2066/4885THRB 1567/4885KMT2A 2431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.